After our recent findings that the amino-terminal portion of rat cGMP-binding, cGMP-specific phosphodiesterase (cGB-PDE) differs from those of bovine and human cGB-PDEs, we found two forms of canine cGB-PDE cDNAs (CFPDE5A1 and CFPDE5A2) in canine lung. Each contained a distinct amino-terminal sequence, CFPDE5A1, possessing an amino-terminal portion with sequence similar to those of bovine and human, and CFPDE5A2, having one similar to that of rat. Other portions coding for the cGMP binding domains and the catalytic domain were conserved. Both CFPDE5A1 and CFPDE5A2 transcripts were detected in the cerebellum, hippocampus, retina, lung, heart, spleen, and thoracic artery. CFPDE5A1 transcripts were particularly abundant in the pylorus, whereas CFPDE5A2 transcripts were quite low in this tissue. CFPDE5A1 and CFPDE5A2 expressed in COS-7 cells had cGMP K m values of 2.68 and 1.97 M, respectively, and both were inhibited by a low concentration of a cGB-PDE inhibitor, Zaprinast. Both CFPDE5A1 and CFPDE5A2 bound cGMP to their allosteric cGMP binding domains, and this cGMP binding was stimulated by 3-isobutyl-1-methylxanthine. Thus, two types of alternative splice variants of canine cGB-PDE have been identified and shown to have similar biological properties in vitro.Cyclic nucleotides including cGMP are well known as second messengers and regulate many functions in various tissues (1-4). Many kinds of cyclic nucleotide phosphodiesterases (PDEs) 1 have been reported as regulators of intracellular cAMP and cGMP concentrations, and based on amino acid sequence analysis and biochemical properties seven PDE families have been recognized in mammalian tissues (5, 6). One of the PDE families, cGMP-binding, cGMP-specific PDE (cGB-PDE), is highly specific for cGMP and is involved in modulation of intracellular cGMP. cGB-PDE activity was found in lung, vascular and tracheal smooth muscle cells, spleen, and platelets (7-11). Recently, we cloned rat and human cGB-PDE cDNAs from lung cDNA libraries and investigated their tissue distribution (12, 13). Our studies showed that high levels of rat cGB-PDE transcripts were observed in cerebellum and intestine besides tissues containing vascular smooth muscle cells. Although the cGMP/cGB-PDE pathway would be expected to play important roles in various tissues, the physiological roles and regulations of cGB-PDE are not well understood.cGB-PDE has been purified from rat and bovine lung, and its characterization has been reported in earlier studies (14,15). Photoaffinity labeling studies have demonstrated that cGB-PDE contains two cGMP binding domains and one catalytic domain (16). The phosphorylation site for cAMP-and cGMPdependent protein kinases has been identified in cGB-PDE (17). Bovine cGB-PDE cDNA isolated from a lung library was revealed to consist of two kinds of domains and the phosphorylation site described above (18). Rat and human cGB-PDEs have also a potential phosphorylation site (12, 13). The phosphorylation of cGB-PDE may participate in regulation of enzymatic activity and inte...